Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment
Immunotolerance is one of the hallmarks of malignant tumors. Tumor cells escape from host immune surveillance through various mechanisms resulting in tumor progression and therapeutic resistance. Interlukin-6 is a proinflammatory cytokine involved in many physiological and pathological processes by...
Saved in:
Main Authors: | Qian Liu, Shengnan Yu, Anping Li, Hanxiao Xu, Xinwei Han, Kongming Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-06-01
|
Series: | Tumor Biology |
Online Access: | https://doi.org/10.1177/1010428317712445 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tailoring of Albumin Nanoparticles Modified with Mannose for Effective Targeting in Immunosuppressive Tumor Microenvironment
by: Alyona B. Kuznetsova, et al.
Published: (2025-06-01) -
Interleukin-6 in the Breast Tumor Microenvironment
by: Sullivan, Nicholas J.
Published: (2011) -
Serum Vascular Endothelial Growth Factor VEGF and Interlukin-8 As a Novel Biomarkers For Early Detection of Ovarian Tumors
by: Baghdad Science Journal
Published: (2015-06-01) -
Targeting Tumor Microenvironments for Cancer Prevention and Therapy
by: Yang, Li V., et al.
Published: (2012) -
Targeting Annexin A2 to reactivate tumor-associated antigens presentation and relieve immune tolerance in liver cancer
by: Min Li, et al.
Published: (2025-06-01)